BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2730380)

  • 1. Amantadine treatment of fatigue associated with multiple sclerosis.
    Cohen RA; Fisher M
    Arch Neurol; 1989 Jun; 46(6):676-80. PubMed ID: 2730380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine therapy for fatigue in multiple sclerosis.
    Murray TJ
    Can J Neurol Sci; 1985 Aug; 12(3):251-4. PubMed ID: 3902184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group.
    Can J Neurol Sci; 1987 Aug; 14(3):273-8. PubMed ID: 2889518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine, fatigue, and multiple sclerosis.
    Rosenberg GA; Appenzeller O
    Arch Neurol; 1988 Oct; 45(10):1104-6. PubMed ID: 2972270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
    Geisler MW; Sliwinski M; Coyle PK; Masur DM; Doscher C; Krupp LB
    Arch Neurol; 1996 Feb; 53(2):185-8. PubMed ID: 8639070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine for fatigue in multiple sclerosis.
    Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
    Foroughipour M; Bahrami Taghanaki HR; Saeidi M; Khazaei M; Sasannezhad P; Shoeibi A
    Acupunct Med; 2013 Mar; 31(1):27-30. PubMed ID: 23151355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.
    Shaygannejad V; Janghorbani M; Ashtari F; Zakeri H
    Neurol Res; 2012 Nov; 34(9):854-8. PubMed ID: 22979982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT; Wang L; Deng XY; Yu G
    J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
    Ashtari F; Fatehi F; Shaygannejad V; Chitsaz A
    Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of amantadine for the treatment of fatigue in multiple sclerosis: a systematic review and meta-analysis.
    Perez DQ; Espiritu AI; Jamora RDG
    Neurodegener Dis Manag; 2020 Dec; 10(6):383-395. PubMed ID: 33012266
    [No Abstract]   [Full Text] [Related]  

  • 16. Amantadine influences cognitive processing in patients with multiple sclerosis.
    Sailer M; Heinze HJ; Schoenfeld MA; Hauser U; Smid HG
    Pharmacopsychiatry; 2000 Jan; 33(1):28-37. PubMed ID: 10721881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amantadine and fatigue of multiple sclerosis.
    Kemp BA; Gora ML
    Ann Pharmacother; 1993; 27(7-8):893-5. PubMed ID: 8364274
    [No Abstract]   [Full Text] [Related]  

  • 18. Amantadine treatment for refractory pain and fatigue in patients with multiple sclerosis.
    Chiba S; Ito M; Matsumoto H
    Can J Neurol Sci; 1992 May; 19(2):309. PubMed ID: 1623455
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome.
    Stein DP; Dambrosia JM; Dalakas MC
    Ann N Y Acad Sci; 1995 May; 753():296-302. PubMed ID: 7611638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.